Literature DB >> 15172104

Prolongation of T(2) relaxation times of hippocampus and amygdala in Alzheimer's disease.

Huali Wang1, Huishu Yuan, Liang Shu, Jingxia Xie, Dai Zhang.   

Abstract

There exists controversy on the MR T(2) relaxometry of hippocampus in Alzheimer's disease (AD). The aim of our study was to examine whether there was a prolonged T(2) relaxation time (T(2)) in hippocampus and amygdala in AD, and whether in AD, the relaxometry data correlated to cognitive performance. In a 1.5 T MR scanner, T(2) of hippocampus and amygdala was measured from 51 patients with AD, 23 subjects with vascular dementia (VaD) and 31 healthy elderly controls. The cognitive performance was assessed with the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog). The AD patients had longer T(2) in hippocampus and amygdala than VaD subjects and healthy elderly controls. In AD, the right hippocampal T(2) was correlated with ADAS-Cog scores, whereas amygdaloid T(2) was not.

Entities:  

Mesh:

Year:  2004        PMID: 15172104     DOI: 10.1016/j.neulet.2004.03.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: applications to AD, MCI, and normal aging.

Authors:  Corinna M Bauer; Hernán Jara; Ron Killiany
Journal:  Neuroimage       Date:  2010-05-02       Impact factor: 6.556

2.  Microstructural changes in the brain mediate the association of AK4, IGFBP5, HSPB2, and ITPK1 with cognitive decline.

Authors:  Namhee Kim; Lei Yu; Robert Dawe; Vladislav A Petyuk; Chris Gaiteri; Philip L De Jager; Julie A Schneider; Konstantinos Arfanakis; David A Bennett
Journal:  Neurobiol Aging       Date:  2019-07-26       Impact factor: 4.673

3.  High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

Authors:  Vijay Antharam; Joanna F Collingwood; John-Paul Bullivant; Mark R Davidson; Saurav Chandra; Albina Mikhaylova; Mary E Finnegan; Christopher Batich; John R Forder; Jon Dobson
Journal:  Neuroimage       Date:  2011-08-16       Impact factor: 6.556

4.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

5.  Longitudinal magnetization transfer imaging in mild to severe Alzheimer disease.

Authors:  S Ropele; R Schmidt; C Enzinger; M Windisch; N P Martinez; F Fazekas
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

6.  Ex vivo T2 relaxation: associations with age-related neuropathology and cognition.

Authors:  Robert J Dawe; David A Bennett; Julie A Schneider; Sue E Leurgans; Aikaterini Kotrotsou; Patricia A Boyle; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2014-02-06       Impact factor: 4.673

7.  Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.

Authors:  M J House; T G St Pierre; J K Foster; R N Martins; R Clarnette
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

8.  Quantitative multi-modal MRI of the Hippocampus and cognitive ability in community-dwelling older subjects.

Authors:  Benjamin S Aribisala; Natalie A Royle; Susana Muñoz Maniega; Maria C Valdés Hernández; Catherine Murray; Lars Penke; Alan Gow; John M Starr; Mark E Bastin; Ian J Deary; Joanna M Wardlaw
Journal:  Cortex       Date:  2013-12-31       Impact factor: 4.027

9.  T2 Relaxometry and Diffusion Tensor Indices of the Hippocampus and Entorhinal Cortex Improve Sensitivity and Specificity of MRI to Detect Amnestic Mild Cognitive Impairment and Alzheimer's Disease Dementia.

Authors:  Michael J Knight; Alfie Wearn; Elizabeth Coulthard; Risto A Kauppinen
Journal:  J Magn Reson Imaging       Date:  2018-09-13       Impact factor: 4.813

10.  The correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer's disease.

Authors:  Zhuren Luo; Xiongjie Zhuang; Dushyant Kumar; Xiurong Wu; Cen Yue; Chengkun Han; Jiancheng Lv
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.